Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.92 Down 0.00(0.04%) Dec 2, 3:59PM EST
Prev Close:0.92
Open:0.95
Bid:0.56 x 500
Ask:1.99 x 300
1y Target Est:4.33
Beta:1.77403
Next Earnings Date:N/A
Day's Range:0.86 - 0.96
52wk Range:0.50 - 4.93
Volume:336,291
Avg Vol (3m):811,892
Market Cap:6.57M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 0.04%6.57M

Key Statistics

Forward P/E (1 yr):4.84
P/S (ttm):2.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.12
Quarterly EPS Est (Dec-16) :-0.25
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback